Welcome!

News Feed Item

Researchers at University of Coimbra, Portugal, Win the Astellas European Foundation's Inaugural Uro-Oncology Grant

CHERTSEY, England, September 29, 2013 /PRNewswire/ --

Dr Celia Gomes wins $150,000 grant to support research looking at NK cell-based adoptive therapy targeting human bladder cancer stem cells

The Astellas European Foundation is delighted to announce that Dr Celia Gomes from the University of Coimbra has been selected as the recipient of the inaugural Uro-Oncology Grant 2013.  

The US$ 150,000 award will support the University of Coimbra's team looking at 'Natural Killer (NK) cell-based adoptive therapy targeting human bladder cancer stem cells: impact on tumour progression using a humanized orthotopic animal model.' This new annual grant complements the Astellas European Foundation's existing annual grant for Functional Urology / Uro-Gynaecology, which has been awarded annually since 2006. The winning project was chosen from 67 applications from a total of 18 countries.

Dr Ayad Abdulahad, Astellas European Foundation Trustee and Senior Vice President Medical Affairs and Health Economics, Astellas Pharma Europe Ltd. commented. "Since 2006 research projects in urology, urological oncology and transplantation have benefited from grants worth over US$3 million, to advance our understanding of medicine and health. Of the 67 applications we received this year, it was felt that Dr Gomes' project focussed on Natural Killer cell-based adoptive therapy targeting bladder cancer stem cells was the most deserving of the grant. The judging panel felt that Dr Gomes' application has real potential. This thoughtfully planned proposal is ultimately looking to improve the prospect for patients living with bladder cancer."

Speaking on behalf of her team, the recipient of the Grant, Dr Celia Gomes said: "The main goal of this project is to evaluate the potential of NK-based adoptive immunotherapy in the eradication of cancer stem cells in bladder cancer and its impact in tumor progression, using a humanised animal model closely resembling the clinical situation. The recognition of the value of our proposal by the evaluation committee of the Astellas Foundation Award on Uro-Oncology 2013 is an additional encouragement to all our efforts in the tasks ahead. We expect to go further inside this subject and thus contribute with pivotal insights for an effective use of adoptive immunotherapy in the treatment of bladder cancer patients."

Previous oncology-related recipients of the Astellas European Foundation Urology Grants have included research teams from France and the UK. Researchers at France's Institut Bergonié led by Dr Nadine Houédé, the recipient of the 2008 Grant, announced they had achieved their goal of identifying six new gene targets that could be used for the development of alternative strategies to treat prostate cancer. Their research, published in the December 2012 issue of Molecular Pharmacology, provided proof of concept that it is possible to identify new alternatives to existing treatments for high grade prostate cancers based on the specific genetic background of these highly aggressive tumours.  

The Astellas European Foundation is a registered charity. It was established in 2005 with the goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society. The Astellas European Foundation Uro-Oncology Grant supports basic medical and related scientific programmes which contribute to advancements in uro-oncology. The winner of the grant was chosen by a jury that includes independent European leaders in the field of uro-oncology.

Notes to Editors

About The Astellas European Foundation

The Astellas European Foundation is a registered charity, formed in 2005, with the long-term goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society. In line with this aim, the Foundation made substantial donations to global charities. The Astellas European Foundation also supports Astellas employees in their private fundraising efforts for charitable causes. The Astellas European Foundation is registered with the Charity Commission for England and Wales, number 1036344.

The Astellas European Foundation was established by funding from Astellas Pharma Inc., but operates independently of it.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Docker containers have brought great opportunities to shorten the deployment process through continuous integration and the delivery of applications and microservices. This applies equally to enterprise data centers as well as the cloud. In his session at 20th Cloud Expo, Jari Kolehmainen, founder and CTO of Kontena, discussed solutions and benefits of a deeply integrated deployment pipeline using technologies such as container management platforms, Docker containers, and the drone.io Cl tool. H...
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution. In his session at @ThingsExpo, Akvelon expert and IoT industry leader Sergey Grebnov provided an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
Kubernetes is a new and revolutionary open-sourced system for managing containers across multiple hosts in a cluster. Ansible is a simple IT automation tool for just about any requirement for reproducible environments. In his session at @DevOpsSummit at 18th Cloud Expo, Patrick Galbraith, a principal engineer at HPE, discussed how to build a fully functional Kubernetes cluster on a number of virtual machines or bare-metal hosts. Also included will be a brief demonstration of running a Galera MyS...
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
Enterprises are universally struggling to understand where the new tools and methodologies of DevOps fit into their organizations, and are universally making the same mistakes. These mistakes are not unavoidable, and in fact, avoiding them gifts an organization with sustained competitive advantage, just like it did for Japanese Manufacturing Post WWII.
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
"Our strategy is to focus on the hyperscale providers - AWS, Azure, and Google. Over the last year we saw that a lot of developers need to learn how to do their job in the cloud and we see this DevOps movement that we are catering to with our content," stated Alessandro Fasan, Head of Global Sales at Cloud Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
As ridesharing competitors and enhanced services increase, notable changes are occurring in the transportation model. Despite the cost-effective means and flexibility of ridesharing, both drivers and users will need to be aware of the connected environment and how it will impact the ridesharing experience. In his session at @ThingsExpo, Timothy Evavold, Executive Director Automotive at Covisint, discussed key challenges and solutions to powering a ride sharing and/or multimodal model in the age ...
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...